|View printer-friendly version|
|August 16, 2005 11:40 a.m.|
|Teva Announces Approval of Paroxetine HCL Tablets|
Jerusalem, Israel, August 16, 2005 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted final approval for the Company's ANDA for Paroxetine Hydrochloride Tablets, 10 mg, 20 mg, 30 mg and 40 mg. Shipment of this product is expected to begin immediately.